J Pediatr Intensive Care 2020; 09(04): 261-264
DOI: 10.1055/s-0040-1710057
Original Article

Impact of Helium-Oxygen Administered via High Velocity Nasal Insufflation on Delivery of Inhaled Nitric Oxide

James H. Hertzog
1   Respiratory Care Services, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
2   Division of Critical Care Medicine, Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
3   Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
,
Katlyn L. Burr
1   Respiratory Care Services, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
,
Angela Stump
1   Respiratory Care Services, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
,
Joel M. Brown
1   Respiratory Care Services, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
,
Scott Penfil
4   Department of Pediatrics, Samuelson Children's Hospital at Sinai, Baltimore, Maryland, United States
,
Kimberly McMahon
2   Division of Critical Care Medicine, Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
3   Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
› Institutsangaben

Abstract

Inhaled nitric oxide (iNO) may be continued during the transition from invasive to noninvasive respiratory support. Upper airway obstruction from laryngeal edema following extubation and lower airway obstruction from asthma and bronchiolitis may be managed with inhaled helium. The coadministration of helium with iNO and the impact on delivered amounts of iNO have not been extensively studied. A bench model simulating a spontaneously breathing infant received iNO at varying preset doses delivered with either helium-oxygen or nitrogen-oxygen via a Vapotherm unit. iNO levels were measured at the simulated trachea. Results from the two conditions were compared using t-tests. When nitrogen-oxygen was used, there was no difference between preset and measured iNO levels. A significant difference was present when helium-oxygen was used, with a 10-fold increase in measured iNO levels compared with preset values. The use of helium resulted in a significant increase in measured iNO at the level of the simulated trachea. Clinicians must be aware that iNO will not be delivered at prescribed doses when used with helium under the conditions used in this study.

Note

This study was conducted at Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.




Publikationsverlauf

Eingereicht: 31. Januar 2020

Angenommen: 27. März 2020

Artikel online veröffentlicht:
24. April 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Dalton HJ. Inhaled nitric oxide: medical miracle or passing fad?. Respir Care 1998; 43: 978-987
  • 2 DiBlasi RM, Dupras D, Kearney C, Costa Jr E, Griebel JL. Nitric oxide delivery by neonatal noninvasive respiratory support devices. Respir Care 2015; 60 (02) 219-230
  • 3 Baudin F, Gagnon S, Crulli B, Proulx F, Jouvet P, Emeriaud G. Modalities and complications associated with the use of high-flow nasal cannula: experience in a pediatric ICU. Respir Care 2016; 61 (10) 1305-1310
  • 4 Tremblay JA, Couture EJ, Albert M. et al. Noninvasive administration of inhaled nitric oxide and its hemodynamic effects in patients with acute right ventricular dysfunction. J Cardiothorac Vasc Anesth 2019; 33 (03) 642-647
  • 5 Tominaga Y, Iwai S, Yamauchi S. et al. Post-extubation inhaled nitric oxide therapy via high-flow nasal cannula after Fontan procedure. Pediatr Cardiol 2019; 40 (05) 1064-1071
  • 6 Nascimento MS, Prado C, Troster EJ, Valério N, Alith MB, Almeida JF. Risk factors for post-extubation stridor in children: the role of orotracheal cannula. Einstein (Sao Paulo) 2015; 13 (02) 226-231
  • 7 Khemani RG, Hotz J, Morzov R. et al. Evaluating risk factors for pediatric post-extubation upper airway obstruction using a physiology-based tool. Am J Respir Crit Care Med 2016; 193 (02) 198-209
  • 8 McGarvey JM, Pollack CV. Heliox in airway management. Emerg Med Clin North Am 2008; 26 (04) 905-920 , viii
  • 9 Morgan SE, Vukin K, Mosakowski S. et al. Use of heliox delivered via high-flow nasal cannula to treat an infant with coronavirus-related respiratory infection and severe acute air-flow obstruction. Respir Care 2014; 59 (11) e166-e170
  • 10 Seliem W, Sultan AM. Heliox delivered by high flow nasal cannula improves oxygenation in infants with respiratory syncytial virus acute bronchiolitis. J Pediatr (Rio J) 2018; 94 (01) 56-61
  • 11 Nie M, Kobayashi H, Sugawara M, Tomita T, Ohara K, Yoshimura H. Helium inhalation enhances vasodilator effect of inhaled nitric oxide on pulmonary vessels in hypoxic dogs. Am J Physiol Heart Circ Physiol 2001; 280 (04) H1875-H1881
  • 12 Phatak RS, Pairaudeau CF, Smith CJ, Pairaudeau PW, Klonin H. Heliox with inhaled nitric oxide: a novel strategy for severe localized interstitial pulmonary emphysema in preterm neonatal ventilation. Respir Care 2008; 53 (12) 1731-1738
  • 13 Petros AJ, Tulloh RM, Wheatley E. Heli-NO: enhanced gas exchange with nitric oxide in helium. Anesth Analg 1996; 83 (04) 888-889
  • 14 Gentile MA. Inhaled medical gases: more to breathe than oxygen. Respir Care 2011; 56 (09) 1341-1357 , discussion 1357–1359
  • 15 Venkataraman ST. Heliox during mechanical ventilation. Respir Care 2006; 51 (06) 632-639
  • 16 Mallinckrodt Pharmaceuticals. INOmax DSir ® Plus © Operation Manual. Series 3. Available at: https://ikariaaust.com/pdfs/INOmax%20DSIR%20Plus%20CE%20Operational%20Manual%20English.pdf . Accessed April 6, 2020